Illustrative image – not actual.Haryana government is in the process to launch a new Pharmaceutical and Medical Devices Manufacturing Policy aimed at attracting investments worth Rs 10,000 crore over the next five years.
The draft policy, developed by the state’s industries and commerce department, seeks to position Haryana as a major manufacturing hub for medicines, medical devices, and other high-value healthcare products. It is designed to reduce India’s dependence on imports of critical inputs such as active pharmaceutical ingredients (APIs), bulk drugs, and advanced medical devices, while strengthening domestic production capabilities. The policy proposes a combination of fiscal and non-fiscal incentives for new and expanding manufacturing units, along with measures to promote research and development, innovation, exports, and skill development.
Haryana Industries and Commerce Secretary Amit Aggarwal said the policy will enhance ease of doing business and support sector-specific industrial growth. The move comes amid strong growth projections for India’s pharmaceutical industry, which is expected to expand significantly by 2030, while addressing supply chain vulnerabilities linked to import dependence in critical healthcare segments.
